[Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D003911:Dextrans / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D005260:Female; D005734:Gangrene / Q000188:drug therapy*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy*; D013806:Theophylline / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D003911:Dextrans; D009539:Nicotinic Acids; D014665:Vasodilator Agents; D013806:Theophylline
Terapia delle arteriopatie obliteranti periferiche mediante perfusioni endoarteriose con dextran a basso peso molecolare e vasodilatatori.